HB1910 104TH GENERAL ASSEMBLY

LRB104 08994 RTM 19050 b

104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
HB1910

Introduced 1/29/2025, by Rep. Anna Moeller

SYNOPSIS AS INTRODUCED:

75 ILCS 5/1-8 new
225 ILCS 85/19.1

Amends the Illinois Local Library Act. Provides that all libraries open to the general public in the State shall maintain a supply of opioid antagonists in an accessible location. Provides that any authorized personnel may administer an opioid antagonist to any person whom the authorized personnel believes, in good faith, to be having an opioid overdose (i) on library grounds; (ii) in the immediate vicinity of the library; or (iii) at a library-sponsored event. Requires libraries to ensure that during all operating hours, there is at least one person present in the library who has completed training in how to recognize and respond to an opioid overdose, including the administration of an opioid antagonist. Requires the Director of the Department of Public Health to identify organizations qualified to offer the training. Provides that the health department of any county where a Library is located may provide, either directly or through providing necessary funds, a supply of opioid antagonists to the library. Allows the Department to adopt rules to implement the provisions. Makes conforming changes in the Pharmacy Practice Act.

A BILL FOR

AN ACT concerning local government.

Be it enacted by the People of the State of Illinois, represented in the General Assembly:

Section 5. The Illinois Local Library Act is amended by adding Section 1-8 as follows:

(75 ILCS 5/1-8 new)

Sec. 1-8. Opioid antagonists.

(a) As used in this Section:

"Authorized personnel" means an employee of the library who has completed training under subsection (d) of this Section.

"Department" means the Department of Public Health.

"Library" means a public library established under or otherwise subject to the requirements of this Act.

"Opioid antagonist" means a drug approved by the federal Food and Drug Administration or recommended for use by the World Health Organization that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the body. "Opioid antagonist" shall be limited to naloxone and other medications approved by the Department for such purpose.

(b) All libraries open to the general public in the State shall maintain a supply of opioid antagonists in an accessible location.

(c) Any authorized personnel may administer an opioid antagonist to any person whom the authorized personnel believes, in good faith, to be having an opioid overdose (i) on library grounds, (ii) in the immediate vicinity of the library, or (iii) at a library-sponsored event. Authorized personnel may carry an opioid antagonist while in the library or at a library-sponsored activity.

(d) Libraries shall ensure that, during all operating hours, there is at least one person present in the library who has completed training in how to recognize and respond to an opioid overdose, including the administration of an opioid antagonist. This training shall be conducted by an organization recognized for providing such training, and may be conducted online or in person. The training must comply with any training requirements under Section 5-23 of the Substance Use Disorder Act and the corresponding rules. The training must also include, but shall not be limited to:

(1) information on how to recognize symptoms of an opioid overdose;

(2) information on drug overdose prevention and recognition;

(3) information on how to perform rescue breathing and resuscitation;

(4) information on how to respond to an emergency involving an opioid overdose;

(5) information on opioid antagonist dosage and administration;

(6) information on the importance of calling 9-1-1 or, if 9-1-1 is not available, other local emergency medical services;

(7) information on care for the overdose victims after administration of the overdose antagonist;

(8) a test demonstrating competency of the knowledge required to recognize an opioid overdose and administer a dose of an opioid antagonist; and

(9) other criteria determined by the Department.

(e) The Director of the Department shall identify organizations qualified to offer the training required by subsection (d) of this Section, and shall make a list of such organizations available on the Department's website.

(f) The health department of any county where a Library is located may provide, either directly or by providing necessary funds, a supply of opioid antagonists to the library. A library that receives opioid antagonists under this subsection (f) shall be considered to be in compliance with subsection (b) of this Section.

(g) The Department may adopt rules as necessary to implement this Section, including, but not limited to, rules establishing additional training curriculum criteria as described in subsection (d) of this Section.

Section 10. The Pharmacy Practice Act is amended by changing Section 19.1 as follows:

(225 ILCS 85/19.1)

(Section scheduled to be repealed on January 1, 2028)

Sec. 19.1. Dispensing opioid antagonists.

(a) Due to the recent rise in opioid-related deaths in Illinois and the existence of an opioid antagonist that can reverse the deadly effects of overdose, the General Assembly finds that in order to avoid further loss where possible, it is responsible to allow greater access of such an antagonist to those populations at risk of overdose.

(b) Notwithstanding any general or special law to the contrary, a licensed pharmacist shall dispense an opioid antagonist in accordance with written, standardized procedures or protocols developed by the Department with the Department of Public Health and the Department of Human Services and filed at the pharmacy before implementation and are available to the Department upon request. This includes dispensation of opioid antagonists to public libraries under Section 1-8 of the Illinois Local Library Act.

(c) Before dispensing an opioid a pharmacist shall inform patients that opioids are addictive and offer to dispense an opioid antagonist.

(d) For the purpose of this Section, "opioid antagonist" means a drug that binds to opioid receptors and blocks or inhibits the effect of opioids acting on those receptors, including, but not limited to, naloxone hydrochloride or any other similarly acting and equally safe drug approved by the U.S. Food and Drug Administration for the treatment of drug overdose.

(Source: P.A. 102-1040, eff. 1-1-23.)